重组人干扰素α-2b对宫颈高危HPV感染患者HPV清除率及免疫功能的影响

2020-04-03 13:35:05丁燕
中国当代医药 2020年5期

丁燕

[摘要]目的 探討重组人干扰素α-2b对宫颈高危人类乳头瘤病毒(HPV)感染患者HPV清除及免疫功能的影响。方法 选择2018年2月~2019年3月就诊于我院的100例宫颈高危HPV感染患者,按照随机数字表法分为对照组和研究组,每组各50例。对照组阴道放置保妇康栓治疗,研究组联合重组人干扰素α-2b栓治疗。比较两组HPV清除情况、宫颈糜烂样改变愈合情况、免疫功能及用药安全性。结果 研究组HPV清除总有效率为88.00%,高于对照组的60.00%,差异有统计学意义(P<0.05);研究组宫颈糜烂样改变愈合总有效率为92.00%,高于对照组的68.00%,差异有统计学意义(P<0.05);两组治疗后白介素-6(IL-6)水平高于治疗前,肿瘤坏死因子-α(TNF-α)水平低于治疗前,研究组IL-6水平高于对照组,TNF-α水平低于对照组,差异有统计学意义(P<0.05);两组治疗过程中均未出现明显不良反应。结论 重组人干扰素α-2b栓治疗宫颈高危HPV感染患者,可提高HPV清除及宫颈糜烂样改变愈合效果,增强机体免疫功能,安全性高。

[关键词]宫颈高危HPV感染;重组人干扰素α-2b;HPV清除;免疫功能;保妇康栓

[中图分类号] R711.3          [文献标识码] A          [文章编号] 1674-4721(2020)2(b)-0143-03

[Abstract] Objective To investigate the effect of Recombinant Human Interferon α-2b on cervical human papillomavirus (HPV) clearance and immune function in patients with high-risk HPV infection. Methods A total of 100 patients with high-risk cervical HPV infection who were admitted to our hospital from February 2018 to March 2019 were selected and were divided into control group and study group according to random number table method, 50 cases in each group. The control group received Baofukang Suppository via vagina, and the study group was added with Recombinant Human Interferon α-2b Suppository. The HPV clearance, cervical erosion-like healing, immune function and medication safety were compared between the two groups. Results The total effectiveness rate of HPV clearance in the study group was 88.00%, higher than that of the control group (60.00%), with statistical difference (P<0.05). The total effectiveness rate of cervical erosion-like healing in the study group was 92.00%, higher than that of the control group (68.00%), with statistical difference (P<0.05). The levels of interleukin-6 (IL-6) after treatment were higher in the two groups, and the levels of tumor necrosis factor-α (TNF-α) was lower compared with those before treatment. The level of IL-6 in the study group was higher than that in the control group, and the level of TNF-α was lower than that in the control group, with statistical differences (P<0.05). There was no obvious adverse reaction during the treatment in two groups. Conclusion In the treatment of high-risk HPV infection of the cervix, Recombinant Human Interferon α-2b Suppository can improve the healing of HPV clearance and cervical erosion-like changes, enhance the immune function of the body, and have high safety.

[Key words] High-risk  cervical HPV infection; Recombinant Human Interferon α-2b; HPV clearance; Immune function

慢性宫颈炎患者常伴有恶露不断、下阴疼痛、白带异常等症状,是女性常见生殖系统疾病,易引起其他病原体感染,其中宫颈高危人乳头瘤病毒(HPV)感染较为常见[1]。宫颈高危HPV感染可促进生殖系统周围皮肤鳞状上皮增生,导致患者出现宫颈癌前病变,甚至引发宫颈癌[2-3]。将宫颈高危HPV感染彻底清除,可有效预防宫颈癌的发生。保妇康栓可增强细胞吞噬能力,促进局部免疫反应,使宫颈糜烂减少,加快糜烂面的愈合,促进组织对HPV的清除[4]。重组人干扰素α-2b有细胞增殖抑制、广谱抗病毒作用,可增强巨噬细胞的杀伤性细胞功能和吞噬能力,使淋巴细胞对靶细胞毒副作用提高,减轻局部组织充血水肿,减少局部组织血流量,促进宫颈糜烂面愈合[5-6]。本研究选择在我院就诊的100例宫颈高危HPV感染患者,分析重组人干扰素α-2b治疗宫颈高危HPV感染的临床效果,现报道如下。……

登录APP查看全文